Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Price:
3 823 JPY
1.16%
Updated:
Apr 30, 2024
Hisamitsu Pharmaceutical Co Inc
Net Income (Common)
|
Hisamitsu Pharmaceutical Co Inc
Net Income (Common) Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
Net Income (Common)
¥14.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥178.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥186.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥121.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥325.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥37.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
See Also
What is Hisamitsu Pharmaceutical Co Inc's Net Income (Common)?
Net Income (Common)
14.3B
JPY
14.3B
JPY
Based on the financial report for Nov 30, 2023, Hisamitsu Pharmaceutical Co Inc's Net Income (Common) amounts to 14.3B JPY.
What is Hisamitsu Pharmaceutical Co Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-5%
-5%
Over the last year, the Net Income (Common) growth was 11%. The average annual Net Income (Common) growth rates for Hisamitsu Pharmaceutical Co Inc have been 17% over the past three years , -3% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
